These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 27373855)

  • 41. Targeting Th2 cells in asthmatic airways.
    Caramori G; Ito K; Adcock IM
    Curr Drug Targets Inflamm Allergy; 2004 Sep; 3(3):243-55. PubMed ID: 15379592
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Emerging drugs for asthma.
    Quirce S; Bobolea I; Barranco P
    Expert Opin Emerg Drugs; 2012 Jun; 17(2):219-37. PubMed ID: 22607631
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis.
    Moss RB
    Ann N Y Acad Sci; 2012 Dec; 1272():49-57. PubMed ID: 23231714
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phase 2, randomised placebo-controlled trial to evaluate the efficacy and safety of an anti-GM-CSF antibody (KB003) in patients with inadequately controlled asthma.
    Molfino NA; Kuna P; Leff JA; Oh CK; Singh D; Chernow M; Sutton B; Yarranton G
    BMJ Open; 2016 Jan; 6(1):e007709. PubMed ID: 26739717
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-IL-4/-13 based therapy in asthma.
    Walsh GM
    Expert Opin Emerg Drugs; 2015 Sep; 20(3):349-52. PubMed ID: 26021492
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting the interleukin-4 and interleukin-13 pathways in severe asthma: current knowledge and future needs.
    Parulekar AD; Kao CC; Diamant Z; Hanania NA
    Curr Opin Pulm Med; 2018 Jan; 24(1):50-55. PubMed ID: 29036019
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Future biologic therapies in asthma.
    Quirce S; Bobolea I; Domínguez-Ortega J; Barranco P
    Arch Bronconeumol; 2014 Aug; 50(8):355-61. PubMed ID: 24685200
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeted therapeutics for severe refractory asthma: monoclonal antibodies.
    Grainge CL; Maltby S; Gibson PG; Wark PA; McDonald VM
    Expert Rev Clin Pharmacol; 2016 Jul; 9(7):927-41. PubMed ID: 27018798
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeting airway inflammation: novel therapies for the treatment of asthma.
    Walsh GM
    Curr Med Chem; 2006; 13(25):3105-11. PubMed ID: 17073650
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lebrikizumab for the treatment of asthma.
    Antoniu SA
    Expert Opin Investig Drugs; 2016 Oct; 25(10):1239-49. PubMed ID: 27554950
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [New drugs for severe asthma].
    Sattler C; Malrin R; Garcia G; Humbert M
    Presse Med; 2016 Nov; 45(11):1043-1055. PubMed ID: 27836376
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacological management of asthma.
    McDonald C; Lipp J
    Aust Fam Physician; 1998; 27(1-2):64-8, 70. PubMed ID: 9503709
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recent trends and directions in the rationalization of pharmacotherapy of bronchial asthma: probing for alternatives.
    Das BP; Sethi A
    Kathmandu Univ Med J (KUMJ); 2006; 4(3):368-78. PubMed ID: 18603937
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting T cells for asthma.
    Heijink IH; Van Oosterhout AJ
    Curr Opin Pharmacol; 2005 Jun; 5(3):227-31. PubMed ID: 15907907
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunomodulation as asthma therapy: where do we stand?
    Barnes PJ
    Eur Respir J Suppl; 1996 Aug; 22():154s-159s. PubMed ID: 8871062
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug therapy of childhood asthma.
    Balachandran A; Shivbalan S; Subramanyam L
    Indian J Pediatr; 2001 Sep; 68 Suppl 4():S12-6. PubMed ID: 11980463
    [TBL] [Abstract][Full Text] [Related]  

  • 57. BuShenYiQi Formula strengthens Th1 response and suppresses Th2-Th17 responses in RSV-induced asthma exacerbated mice.
    Wang J; Wu J; Kong L; Nurahmat M; Chen M; Luo Q; Li B; Wu X; Dong J
    J Ethnopharmacol; 2014 May; 154(1):131-47. PubMed ID: 24704667
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cytokine antagonists for the treatment of asthma: progress to date.
    Antoniu SA
    BioDrugs; 2009; 23(4):241-51. PubMed ID: 19697966
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetic/pharmacodynamic profile of reslizumab in asthma.
    Matera MG; Rogliani P; Calzetta L; Cazzola M
    Expert Opin Drug Metab Toxicol; 2018 Feb; 14(2):239-245. PubMed ID: 29268638
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IL-13 and the IL-13 receptor as therapeutic targets for asthma and allergic disease.
    Mitchell J; Dimov V; Townley RG
    Curr Opin Investig Drugs; 2010 May; 11(5):527-34. PubMed ID: 20419598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.